Eur Respir J 2005; 26:586-593
Copyright ©ERS Journals Ltd 2005
Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity
V. Cottin1,
H. Nunes2,
P-Y. Brillet3,
P. Delaval4,
G. Devouassoux5,
I. Tillie-Leblond6,
D. Israel-Biet7,
I. Court-Fortune8,
D. Valeyre2,
J-F. Cordier1 the Groupe d'Etude et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P)
1 Service de Pneumologie, Centre de référence des maladies orphelines pulmonaires, Hôpital Cardiovasculaire et Pneumologique Louis Pradel, Université Claude Bernard, and UMR 754 INRA-ENVL-UCBL, Lyon, and 2 Service de pneumologie, and 3 Service de radiologie, Hôpital Avicenne, Bobigny, 4 Dépt de pneumologie et cardiologie, Centre Hospitalier Universitaire de Rennes, 5 Service de pneumologie, centre hospitalier Lyon Sud, Pierre Bénite, 6 Service de pneumologie, Centre Hospitalier Universitaire de Lille, 7 Service de pneumologie et soins intensifs, Hôpital européen G. Pompidou, Paris, and 8 Service de pneumologie, Hôpital Nord, Saint-Etienne, France.
CORRESPONDENCE: J-F. Cordier, Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires, Hôpital Cardiovasculaire et Pneumologique Louis Pradel, 69677 Lyon (Bron), France. Fax: 33 472357653. E-mail: germop{at}univ-lyon1.fr
Keywords: Emphysema, interstitial lung disease, pulmonary arterial hypertension, pulmonary fibrosis
Received: February 23, 2005
Accepted June 29, 2005
The syndrome resulting from combined pulmonary fibrosis and emphysema has not been comprehensively described.
The current authors conducted a retrospective study of 61 patients with both emphysema of the upper zones and diffuse parenchymal lung disease with fibrosis of the lower zones of the lungs on chest computed tomography.
Patients (all smokers) included 60 males and one female, with a mean age of 65 yrs. Dyspnoea on exertion was present in all patients. Basal crackles were found in 87% and finger clubbing in 43%. Pulmonary function tests were as follows (mean±SD): total lung capacity 88%±17, forced vital capacity (FVC) 88%±18, forced expiratory volume in one second (FEV1) 80%±21 (% predicted), FEV1/FVC 69%±13, carbon monoxide diffusion capacity of the lung 37%±16 (% predicted), carbon monoxide transfer coefficient 46%±19. Pulmonary hypertension was present in 47% of patients at diagnosis, and 55% during follow-up. Patients were followed for a mean of 2.1±2.8 yrs from diagnosis. Survival was 87.5% at 2 yrs and 54.6% at 5 yrs, with a median of 6.1 yrs. The presence of pulmonary hypertension at diagnosis was a critical determinant of prognosis.
The authors hereby individualise the computer tomography-defined syndrome of combined pulmonary fibrosis and emphysema characterised by subnormal spirometry, severe impairment of gas exchange, high prevalence of pulmonary hypertension, and poor survival.
This article has been cited by other articles:

|
 |

|
 |
 
Clinical Assembly contribution to the celebration, B. Balbi, V. Cottin, S. Singh, W. De Wever, F. J. F. Herth, and C. Robalo Cordeiro
Smoking-related lung diseases: a clinical perspective
Eur. Respir. J.,
February 1, 2010;
35(2):
231 - 233.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Sergiacomi, F. Bolacchi, M. Cadioli, M. L. Angeli, F. Fucci, S. Crusco, P. Rogliani, G. Pezzuto, F. Romeo, E. Mariano, et al.
Combined Pulmonary Fibrosis and Emphysema: 3D Time-resolved MR Angiographic Evaluation of Pulmonary Arterial Mean Transit Time and Time to Peak Enhancement
Radiology,
February 1, 2010;
254(2):
601 - 608.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Munson
Combined pulmonary fibrosis and emphysema: a high-pressure situation
Eur. Respir. J.,
January 1, 2010;
35(1):
9 - 11.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Cottin, J. Le Pavec, G. Prevot, H. Mal, M. Humbert, G. Simonneau, J-F. Cordier, and GERM"O"P
Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome
Eur. Respir. J.,
January 1, 2010;
35(1):
105 - 111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
The Task Force for the Diagnosis and Treatment of, N. Galie, M. M. Hoeper, M. Humbert, A. Torbicki, J-L. Vachiery, J. A. Barbera, M. Beghetti, P. Corris, S. Gaine, et al.
Guidelines for the diagnosis and treatment of pulmonary hypertension
Eur. Respir. J.,
December 1, 2009;
34(6):
1219 - 1263.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Authors/Task Force Members, N. Galie, M. M. Hoeper, M. Humbert, A. Torbicki, J.-L. Vachiery, J. A. Barbera, M. Beghetti, P. Corris, S. Gaine, et al.
Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)
Eur. Heart J.,
October 2, 2009;
30(20):
2493 - 2537.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E Weitzenblum and A Chaouat
Cor pulmonale
Chronic Respiratory Disease,
August 1, 2009;
6(3):
177 - 185.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Cottin and J.-F. Cordier
The Syndrome of Combined Pulmonary Fibrosis and Emphysema
Chest,
July 1, 2009;
136(1):
1 - 2.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mejia, G. Carrillo, J. Rojas-Serrano, A. Estrada, T. Suarez, D. Alonso, E. Barrientos, M. Gaxiola, C. Navarro, and M. Selman
Idiopathic Pulmonary Fibrosis and Emphysema: Decreased Survival Associated With Severe Pulmonary Arterial Hypertension
Chest,
July 1, 2009;
136(1):
10 - 15.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Simonneau, I. M. Robbins, M. Beghetti, R. N. Channick, M. Delcroix, C. P. Denton, C. G. Elliott, S. P. Gaine, M. T. Gladwin, Z.-C. Jing, et al.
Updated clinical classification of pulmonary hypertension.
J. Am. Coll. Cardiol.,
June 30, 2009;
54(1 Suppl):
S43 - S54.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Hoeper, J. A. Barbera, R. N. Channick, P. M. Hassoun, I. M. Lang, A. Manes, F. J. Martinez, R. Naeije, H. Olschewski, J. Pepke-Zaba, et al.
Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension.
J. Am. Coll. Cardiol.,
June 30, 2009;
54(1 Suppl):
S85 - S96.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Devouassoux, V. Cottin, H. Liote, E. Marchand, I. Frachon, A. Schuller, F. Bejui-Thivolet, J-F. Cordier, and the Groupe d'Etudes et de Recherche sur les Maladi
Characterisation of severe obliterative bronchiolitis in rheumatoid arthritis
Eur. Respir. J.,
May 1, 2009;
33(5):
1053 - 1061.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Cottin, N. Fabien, C. Khouatra, A. Moreira, and J-F. Cordier
Anti-elastin autoantibodies are not present in combined pulmonary fibrosis and emphysema
Eur. Respir. J.,
January 1, 2009;
33(1):
219 - 221.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Lynch III
Idiopathic Pulmonary Fibrosis, Nonspecific Interstitial Pneumonia/Fibrosis, and Sarcoidosis
ACCP Pulmonary Med Brd Rev,
January 1, 2009;
25(0):
635 - 686.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Make and F. J. Martinez
Assessment of Patients with Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
December 15, 2008;
5(9):
884 - 890.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Attili, E. A. Kazerooni, B. H. Gross, K. R. Flaherty, J. L. Myers, and F. J. Martinez
Smoking-related Interstitial Lung Disease: Radiologic-Clinical-Pathologic Correlation1
RadioGraphics,
September 1, 2008;
28(5):
1383 - 1396.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Behr and J. H. Ryu
Pulmonary hypertension in interstitial lung disease
Eur. Respir. J.,
June 1, 2008;
31(6):
1357 - 1367.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Antoniou, D. M. Hansell, M. B. Rubens, K. Marten, S. R. Desai, N. M. Siafakas, A. G. Nicholson, R. M. du Bois, and A. U. Wells
Idiopathic Pulmonary Fibrosis: Outcome in Relation to Smoking Status
Am. J. Respir. Crit. Care Med.,
January 15, 2008;
177(2):
190 - 194.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. F. Shorr, J. L. Wainright, C. S. Cors, C. J. Lettieri, and S. D. Nathan
Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant
Eur. Respir. J.,
October 1, 2007;
30(4):
715 - 721.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Noth and F. J. Martinez
Recent Advances in Idiopathic Pulmonary Fibrosis
Chest,
August 1, 2007;
132(2):
637 - 650.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Nathan, O. A. Shlobin, S. Ahmad, S. Urbanek, and S. D. Barnett
Pulmonary Hypertension and Pulmonary Function Testing in Idiopathic Pulmonary Fibrosis
Chest,
March 1, 2007;
131(3):
657 - 663.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Hamada, S. Nagai, S. Tanaka, T. Handa, M. Shigematsu, T. Nagao, M. Mishima, M. Kitaichi, and T. Izumi
Significance of Pulmonary Arterial Pressure and Diffusion Capacity of the Lung as Prognosticator in Patients With Idiopathic Pulmonary Fibrosis
Chest,
March 1, 2007;
131(3):
650 - 656.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. Aduen, D. A. Zisman, S. I. Mobin, C. Venegas, F. Alvarez, M. Biewend, H. I. Jolles, and C. A. Keller
Retrospective Study of Pulmonary Function Tests in Patients Presenting With Isolated Reduction in Single-Breath Diffusion Capacity: Implications for the Diagnosis of Combined Obstructive and Restrictive Lung Disease
Mayo Clin. Proc.,
January 1, 2007;
82(1):
48 - 54.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Gauldie, M. Kolb, K. Ask, G. Martin, P. Bonniaud, and D. Warburton
Smad3 Signaling Involved in Pulmonary Fibrosis and Emphysema
Proceedings of the ATS,
November 1, 2006;
3(8):
696 - 702.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Chua and G. J. Laurent
Neutrophil elastase: mediator of extracellular matrix destruction and accumulation.
Proceedings of the ATS,
July 1, 2006;
3(5):
424 - 427.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. Martinez and M. P. Keane
Update in diffuse parenchymal lung diseases 2005.
Am. J. Respir. Crit. Care Med.,
May 15, 2006;
173(10):
1066 - 1071.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Daniil, A. Koutsokera, and K. Gourgoulianis
Combined pulmonary fibrosis and emphysema in patients exposed to agrochemical compounds.
Eur. Respir. J.,
February 1, 2006;
27(2):
434 - 434.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. Martinez
Idiopathic Interstitial Pneumonias: Usual Interstitial Pneumonia versus Nonspecific Interstitial Pneumonia.
Proceedings of the ATS,
January 1, 2006;
3(1):
81 - 95.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. Martinez and K. Flaherty
Pulmonary function testing in idiopathic interstitial pneumonias.
Proceedings of the ATS,
January 1, 2006;
3(4):
315 - 321.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the European Respiratory Society.
|
|